Back
Bumble, Inc. Vs. Monopar Therapeutics, Inc. Industry Stock Comparison
Sell
33
BMBL
Bumble, Inc.
Last Price:
$3.55
Seasonality Move:
-29.87%
Sell
39
MNPR
Monopar Therapeutics, Inc.
Last Price:
$71.43
Seasonality Move:
36.18%
Sell
33
Bumble, Inc. (BMBL)
is a Sell
Is Bumble, Inc. a Buy, Sell or Hold?
-
The current Bumble, Inc. [BMBL] share price is $3.46. The Score for BMBL is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
BMBL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Monopar Therapeutics, Inc. [MNPR] share price is $75.12. The Score for MNPR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BMBL Stock Price Chart
What is Bumble, Inc.'s stock price today?
-
The Bumble, Inc. share price today is $3.46Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMBL is experiencing buying pressure, which is a positive indicator for future bullish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics, Inc.'s stock price today?
-
The Monopar Therapeutics, Inc. share price today is $75.12Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.
BMBL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.26 | Sell |
| Relative Strength Index (14 RSI): | 35.59 | Sell |
| Chaikin Money Flow: | 3200471 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.43 - 3.83) | Sell |
| Bollinger Bands (100): | (4.28 - 6.98) | Sell |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.87 | Sell |
| Relative Strength Index (14 RSI): | 42.12 | Sell |
| Chaikin Money Flow: | -62944 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (76.34 - 86.56) | Sell |
| Bollinger Bands (100): | (44.09 - 88.71) | Buy |
BMBL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.65 | Sell |
| 20-day SMA: | 3.57 | Sell |
| 50-day SMA: | 4.53 | Sell |
| 200-day SMA: | 5.47 | Sell |
| 8-day EMA: | 3.6 | Sell |
| 20-day EMA: | 3.76 | Sell |
| 50-day EMA: | 4.42 | Sell |
| 200-day EMA: | 5.79 | Sell |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 77.09 | Sell |
| 20-day SMA: | 81.11 | Sell |
| 50-day SMA: | 83.94 | Sell |
| 200-day SMA: | 51.58 | Buy |
| 8-day EMA: | 77.09 | Sell |
| 20-day EMA: | 79.63 | Sell |
| 50-day EMA: | 78.25 | Sell |
| 200-day EMA: | 56.2 | Buy |
Bumble, Inc. Earnings Growth & BMBL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $1.42 per share.
Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.
Bumble, Inc. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics, Inc. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||